๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-06-25

Integrated Cancer Repository for Cancer Research (NCT02012699)

๐ŸŸข Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: University of Nebraska

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies.

Who can join: Review the eligibility criteria below.

Location: Advent Health โ€” Greenwood Village, Colorado

Age range: 19 Years to 110 Years

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (42 Sites)

Showing the first 25 of 42 sites.

  • Advent Health โ€” Greenwood Village, Colorado
  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital โ€” Manchester, Connecticut
  • Florida Hospital Memorial Medical Center โ€” Daytona Beach, Florida
  • Florida Hospital DeLand โ€” DeLand, Florida
  • Florida Hospital FISH โ€” Orange City, Florida
  • Florida Hospital Flagler โ€” Palm Coast, Florida
  • Tallahassee Memorial Hospital โ€” Tallahassee, Florida
  • Rush-Copley Cancer Care Center โ€” Aurora, Illinois
  • Rush-Copley Healthcare Center โ€” Yorkville, Illinois
  • Parkview Research Center โ€” Fort Wayne, Indiana
  • Methodist Jennie Edmundson Hospital โ€” Council Bluffs, Iowa
  • Covenant Medical Center, Inc โ€” Waterloo, Iowa
  • Saint Luke's Cancer Instititute - South โ€” Overland Park, Kansas
  • Northwest Hospital โ€” Randallstown, Maryland
  • William E. Kahlert Regional Cancer Center โ€” Westminster, Maryland
  • Holyoke Medical Center โ€” Holyoke, Massachusetts
  • Riverwood Healthcare Center โ€” Aitkin, Minnesota
  • Essentia Health-St. Joseph's Medical Center โ€” Brainerd, Minnesota
  • Essentia Health - Duluth Clinic โ€” Duluth, Minnesota
  • St. Luke's Hospital of Duluth โ€” Duluth, Minnesota
  • Lake Region Healthcare โ€” Fergus Falls, Minnesota
  • Saint Luke's Cancer Institute, East โ€” Kansas City, Missouri
  • Saint Luke's Cancer Institute โ€” Kansas City, Missouri
  • Saint Luke's Cancer Institute, Kansas City North โ€” Kansas City, Missouri
  • Saint Luke's Cancer Institute, Liberty โ€” Liberty, Missouri

๐Ÿ“ž Contact the Study Coordinator

Phone: (402) 559-0568

Email: artem.pachikov@unmc.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—